Abstract Background: Myocardial ischemia-reperfusion injury (MIRI) is a major complication of reperfusion therapy for acute myocardial infarction and is strongly associated with adverse patient outcomes; however, no specific treatment options are currently available. This study aimed to investigate the protective effects of adipose-derived stem cell exosomes (ADSC-Exos) against MIRI and the underlying mechanisms. Methods: We established an hypoxia/reoxygenation model in H9C2 cell line and a MIRI animal model in C57BL/6J mice. Results: The results showed that pretreatment with ADSC-Exos significantly improved cell viability, reduced cell death, enhanced cardiac function in mice, and reduced the area of myocardial infarction. Mechanistically, ADSC-Exos upregulated Mitochondrial fusion protein 2( Mfn2 )expression, improved mitochondrial membrane potential, and corrected mitochondrial ultrastructural abnormalities. ADSC-Exos upregulated the Glutathione peroxidase 4 (GPX4 )signaling pathway, resulting in decreased levels of mitochondrial reactive oxygen species (ROS), lipid peroxidation-derived malondialdehyde (MDA), and labile ferrous ions (Fe²⁺), thereby effectively suppressing ferroptosis. Importantly, through the establishment of a Mfn2-overexpressing cell line, we validated that Overexpression of Mfn2 was found to recapitulate the cytoprotective effects elicited by ADSC-Exos, specifically by suppressing ferroptosis via GPX4 upregulation. Conclusion: Collectively, this study elucidates that ADSC-Exos preserve mitochondrial homeostasis and inhibit ferroptosis in cardiomyocytes, thereby mitigating MIRI. Notably, the Mfn2/GPX4 axis serves as a pivotal downstream effector mediating the protective actions of ADSC-Exos. These findings establish a theoretical foundation for the development of cell-free therapeutic strategies targeting this signaling cascade.